國立虎尾科技大學 |

Diabetes Mellitus = A risk factor for Alzheimer's Disease /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Diabetes Mellitus/ edited by Yusaku Nakabeppu, Toshiharu Ninomiya.
Reminder of title:	A risk factor for Alzheimer's Disease /
other author:	Nakabeppu, Yusaku.
Description:	VI, 248 p. 49 illus., 28 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Neurosciences. -
Online resource:	https://doi.org/10.1007/978-981-13-3540-2
ISBN:	9789811335402

Diabetes Mellitus = A risk factor for Alzheimer's Disease /
Diabetes MellitusA risk factor for Alzheimer's Disease /[electronic resource] :edited by Yusaku Nakabeppu, Toshiharu Ninomiya. - 1st ed. 2019. - VI, 248 p. 49 illus., 28 illus. in color.online resource. - Advances in Experimental Medicine and Biology,11280065-2598 ;. - Advances in Experimental Medicine and Biology,889.

Chapter 1 Origins of brain insulin and its function -- Chapter 2 Epidemiological evidence of the relationship between diabetes and dementia -- Chapter 3 Molecular pathophysiology of insulin depletion, mitochondrial dysfunction, and oxidative stress in Alzheimer’s Disease Brain -- Chapter 4 The Full Spectrum of Alzheimer's Disease is Rooted in Metabolic -- Derangements That Drive Type 3 Diabetes -- Chapter 5 The roles of apolipoprotein E, lipids and glucose in the pathogenesis of Alzheimer’s disease -- Chapter 6 Molecular connection between diabetes and dementia -- Chapter 7 Type II Diabetes mellitus accelerates age-dependent A pathology in cynomolgus monkey brain -- Chapter 8 Diabetes-related dementia -- Chapter 9 Tortuous paths of insulin signaling and mitochondria in Alzheimer's disease -- Chapter 10 Mammalian target of rapamycin at the crossroad between Alzheimer’s Disease and diabetes -- Chapter 11 Therapeutic strategies for Alzheimer’s disease in the view of diabetes mellitus.

This book describes the precise mechanisms by which insulin resistance and diabetes mellitus (DM) act as risk factors for Alzheimer’s disease (AD). It opens by discussing the de novo synthesis of insulin in the brain and its functional significance with regard to glucose metabolism and maintenance of neuronal function in the brain. The epidemiological evidence that DM is a risk factor for the development of dementia, including AD as well as vascular dementia, is then examined. Subsequent chapters explore in depth the mechanisms involved in this relationship, including abnormal protein processing, dysregulated glucose metabolism, impaired insulin signaling, and mitochondrial dysfunction. The molecular interactions between diabetes and AD are fully discussed, highlighting the pathological molecular mechanisms induced by diabetes that promote and accelerate AD pathology. Finally, diagnostic biomarkers and potential therapeutic approaches for AD are considered on the basis of the presented evidence. In providing answers to the critical questions of whether and why DM is a risk factor for AD, this book will hold appeal for a wide interdisciplinary audience.

ISBN: 9789811335402

Standard No.: 10.1007/978-981-13-3540-2doiSubjects--Topical Terms:

593561
Neurosciences.

LC Class. No.: RC321-580

Dewey Class. No.: 612.8

Diabetes Mellitus = A risk factor for Alzheimer's Disease /
LDR:03602nam a22003975i 4500 001 1004207
003 DE-He213
005 20200706081322.0
007 cr nn 008mamaa
008 210106s2019 si | s |||| 0|eng d
020 $a 9789811335402 $9 978-981-13-3540-2
024 7 $a 10.1007/978-981-13-3540-2 $2 doi
035 $a 978-981-13-3540-2
050 4 $a RC321-580
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
072 7 $a PSAN $2 thema
082 0 4 $a 612.8 $2 23
245 1 0 $a Diabetes Mellitus $h [electronic resource] : $b A risk factor for Alzheimer's Disease / $c edited by Yusaku Nakabeppu, Toshiharu Ninomiya.
250 $a 1st ed. 2019.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a VI, 248 p. 49 illus., 28 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Advances in Experimental Medicine and Biology, $x 0065-2598 ; $v 1128
505 0 $a Chapter 1 Origins of brain insulin and its function -- Chapter 2 Epidemiological evidence of the relationship between diabetes and dementia -- Chapter 3 Molecular pathophysiology of insulin depletion, mitochondrial dysfunction, and oxidative stress in Alzheimer’s Disease Brain -- Chapter 4 The Full Spectrum of Alzheimer's Disease is Rooted in Metabolic -- Derangements That Drive Type 3 Diabetes -- Chapter 5 The roles of apolipoprotein E, lipids and glucose in the pathogenesis of Alzheimer’s disease -- Chapter 6 Molecular connection between diabetes and dementia -- Chapter 7 Type II Diabetes mellitus accelerates age-dependent A pathology in cynomolgus monkey brain -- Chapter 8 Diabetes-related dementia -- Chapter 9 Tortuous paths of insulin signaling and mitochondria in Alzheimer's disease -- Chapter 10 Mammalian target of rapamycin at the crossroad between Alzheimer’s Disease and diabetes -- Chapter 11 Therapeutic strategies for Alzheimer’s disease in the view of diabetes mellitus.
520 $a This book describes the precise mechanisms by which insulin resistance and diabetes mellitus (DM) act as risk factors for Alzheimer’s disease (AD). It opens by discussing the de novo synthesis of insulin in the brain and its functional significance with regard to glucose metabolism and maintenance of neuronal function in the brain. The epidemiological evidence that DM is a risk factor for the development of dementia, including AD as well as vascular dementia, is then examined. Subsequent chapters explore in depth the mechanisms involved in this relationship, including abnormal protein processing, dysregulated glucose metabolism, impaired insulin signaling, and mitochondrial dysfunction. The molecular interactions between diabetes and AD are fully discussed, highlighting the pathological molecular mechanisms induced by diabetes that promote and accelerate AD pathology. Finally, diagnostic biomarkers and potential therapeutic approaches for AD are considered on the basis of the presented evidence. In providing answers to the critical questions of whether and why DM is a risk factor for AD, this book will hold appeal for a wide interdisciplinary audience.
650 0 $a Neurosciences. $3 593561
650 0 $a Diabetes. $3 582755
650 0 $a Neurology . $3 1253459
650 2 4 $a Neurology. $3 593894
700 1 $a Nakabeppu, Yusaku. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1226716
700 1 $a Ninomiya, Toshiharu. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1226717
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811335396
776 0 8 $i Printed edition: $z 9789811335419
830 0 $a Advances in Experimental Medicine and Biology, $x 0065-2598 ; $v 889 $3 1253792
856 4 0 $u https://doi.org/10.1007/978-981-13-3540-2
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)